<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Richmond BizSense &#187; Intelliject</title>
	<atom:link href="http://www.richmondbizsense.com/tag/intelliject/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.richmondbizsense.com</link>
	<description>Richmond&#039;s Homepage For Business News</description>
	<lastBuildDate>Thu, 09 Feb 2012 18:51:01 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>A shot of adrenaline for Intelliject</title>
		<link>http://www.richmondbizsense.com/2011/08/02/a-shot-of-adrenaline-for-intelliject/</link>
		<comments>http://www.richmondbizsense.com/2011/08/02/a-shot-of-adrenaline-for-intelliject/#comments</comments>
		<pubDate>Tue, 02 Aug 2011 11:09:12 +0000</pubDate>
		<dc:creator>Michael Schwartz</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Intelliject]]></category>

		<guid isPermaLink="false">http://www.richmondbizsense.com/?p=31352</guid>
		<description><![CDATA[<br/>After seven years of development and regulatory wrangling, a Shockoe Slip-based drug device maker has moved a big step closer to getting its flagship product to market. But a huge obstacle still looms. ]]></description>
		<wfw:commentRss>http://www.richmondbizsense.com/2011/08/02/a-shot-of-adrenaline-for-intelliject/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>Monday Q&amp;A: An injection of patience</title>
		<link>http://www.richmondbizsense.com/2011/04/18/monday-qa-an-injection-of-patience/</link>
		<comments>http://www.richmondbizsense.com/2011/04/18/monday-qa-an-injection-of-patience/#comments</comments>
		<pubDate>Mon, 18 Apr 2011 09:58:06 +0000</pubDate>
		<dc:creator>Michael Schwartz</dc:creator>
				<category><![CDATA[Monday Q&A]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Intelliject]]></category>
		<category><![CDATA[Spencer Williamson]]></category>

		<guid isPermaLink="false">http://www.richmondbizsense.com/?p=27961</guid>
		<description><![CDATA[<br/>Richmond drug device maker Intelliject recently received its 90th patent. ]]></description>
		<wfw:commentRss>http://www.richmondbizsense.com/2011/04/18/monday-qa-an-injection-of-patience/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Local drug firm sells tech for $25 million</title>
		<link>http://www.richmondbizsense.com/2009/12/01/local-drug-firm-sells-tech-for-25-million/</link>
		<comments>http://www.richmondbizsense.com/2009/12/01/local-drug-firm-sells-tech-for-25-million/#comments</comments>
		<pubDate>Tue, 01 Dec 2009 11:45:49 +0000</pubDate>
		<dc:creator>Al Harris</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Eric Edwards]]></category>
		<category><![CDATA[Evan Edwards]]></category>
		<category><![CDATA[Intelliject]]></category>
		<category><![CDATA[Sanofi-aventis]]></category>

		<guid isPermaLink="false">http://www.richmondbizsense.com/?p=13682</guid>
		<description><![CDATA[<br/>Intelliject, a Richmond-based pharmaceutical company, just closed a $25 million licensing deal with drug maker Sanofi-aventis]]></description>
		<wfw:commentRss>http://www.richmondbizsense.com/2009/12/01/local-drug-firm-sells-tech-for-25-million/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
	</channel>
</rss>

